关于中风后抑郁症治疗选择的全面概述
Alberto Raggi1, Alessandro Serretti2, Raffaele Ferri3
1Unit of Neurology, G.B. Morgagni - L. Pierantoni Civic Hospital, Forlì.
International clinical psychopharmacology
|January 3, 2024
概括
脑卒中后抑郁症 (PSD) 影响了近三分之一的中风幸存者,影响了恢复. 本综述探讨了药理和创新的非药理治疗方法,以改善中风后抑郁症的结果.
科学领域:
- 神经学 神经学
- 精神病学是一个精神病学.
- 康复医学 康复医学 康复医学
背景情况:
- 脑卒中后抑郁症 (PSD) 是一种常见的并发症,影响高达三分之一的中风幸存者.
- PSD与中风后的功能恢复和整体结果较差有关.
- 有效的管理策略对于改善中风患者的生活质量至关重要.
结论:
- 脑卒中后抑郁症需要有效的治疗策略.
- 药物和新兴的非药物疗法为管理PSD提供了可行的选择.
- 持续的研究对于优化中风幸存者的抑郁症治疗至关重要.
更多相关视频
04:29Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
28.6K
08:54Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
Published on: June 6, 2025
271
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
239
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
239
Antidepressant Drugs: Overview
503
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
503
Electroconvulsive Therapy
41
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
41
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
398
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
398
Depression: Overview
248
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
248
Alzheimer's Disease: Treatment
195
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
195
